A 53-year-old woman arrived at a Ukrainian infectious diseases hospital on the sixteenth day of a baffling illness. She was febrile, with a temperature climbing to 38.4 degrees Celsius, and she showed the classic clinical signature of meningoencephalitis: headache, signs of meningeal irritation, and evidence that the inflammation had spread beyond the protective membranes of the brain into the brain tissue itself. She was, importantly, immunocompetent, with no obvious weakness in the immune defenses that normally keep opportunistic pathogens in check. What her physicians found when they examined her cerebrospinal fluid would turn her case into a report worth publishing, because it captured a diagnostic puzzle that clinicians in tick-endemic regions rarely see so clearly: two neurotropic viruses occupying the same patient at the same time.
The team, led by Olena Zubach of Danylo Halytsky Lviv National Medical University together with colleagues at the Lviv Oblast Clinical Hospital of Infectious Diseases and the Lviv Oblast Center for Diseases Control and Prevention, performed a lumbar puncture and recovered cerebrospinal fluid for analysis. The fluid showed moderate lymphocytic pleocytosis, an elevated count of lymphocytes that serves as a cellular fingerprint of viral central nervous system infection. Serological testing then delivered the first answer. The patient’s serum contained diagnostic levels of both IgM and IgG antibodies against tick-borne encephalitis virus, the flavivirus transmitted by Ixodes ticks across much of Europe and Asia, while her cerebrospinal fluid carried IgG antibodies against the same virus. Combined with her epidemiological history, which included travel to an endemic region and a documented tick bite, the diagnosis of tick-borne encephalitis was firmly established.
But the cerebrospinal fluid held a second surprise. Polymerase chain reaction testing detected DNA from human herpesvirus 7, a betaherpesvirus better known as a ubiquitous, usually silent passenger in the human population. The detection of HHV-7 DNA in the central nervous system of an immunocompetent patient already fighting tick-borne encephalitis raised an immediate and difficult question: was the herpesvirus an innocent bystander, a latent virus passively present in the sample, or was it actively replicating and contributing to the neurological damage? The authors of the report, published in Virology Journal, framed their case precisely around this interpretive dilemma, and their literature review situates it within a growing but still incomplete body of evidence on viral co-infections of the brain.
Human herpesvirus 7 was first isolated in 1990 and is closely related to human herpesvirus 6, the other member of the Roseolovirus genus. Like its relative, HHV-7 infects the vast majority of people early in life, typically causing a mild febrile illness or the childhood rash known as roseola, after which it establishes lifelong latency in T lymphocytes and other tissues. In healthy carriers, the virus usually remains dormant, controlled by cellular immunity. Reactivation is a well-recognized complication in transplant recipients and other immunosuppressed patients, in whom HHV-7 has been implicated in febrile syndromes, encephalitis, and graft complications. Detection of the virus in the cerebrospinal fluid of an immunocompetent adult, however, is genuinely uncommon, and determining whether such detection reflects true productive infection rather than latent viral DNA is a persistent technical challenge in clinical virology.
This challenge stems from the biology of herpesviruses themselves. Latent HHV-7 genomes can persist in cells that traffic through the central nervous system, and PCR amplification alone cannot always distinguish between low-level latent DNA and the replicating viral genomes that would indicate an active infection. Quantitative viral load measurements, detection of viral mRNA transcripts, and demonstration of intrathecal antibody synthesis are among the tools virologists use to strengthen the case for active replication, but each has limitations. In the Ukrainian case, the detection of HHV-7 DNA in the cerebrospinal fluid was unexpected precisely because the patient’s immune status gave no obvious reason for herpesvirus reactivation, and the clinical picture was already well explained by tick-borne encephalitis. The co-occurrence forced the clinicians to consider whether the two viruses might be interacting in ways that shaped the severity or course of the disease.
Viral co-infections of the central nervous system are an area of intensifying research interest, and the mechanisms by which one virus can modify the pathogenesis of another are varied and, in many cases, still hypothetical. Direct interference is one possibility: one virus may upregulate or suppress cellular pathways that the second virus depends on. Immune-mediated effects are another. A primary viral infection can transiently perturb the antiviral response, altering interferon signaling, T cell function, or cytokine profiles in ways that permit a second, normally controlled agent to reactivate from latency. Tick-borne encephalitis virus itself is known to affect immune cells, and herpesviruses such as HHV-7 reside within CD4-positive T lymphocytes, creating a plausible cellular environment in which acute flaviviral infection and herpesvirus reactivation could intersect. The authors emphasize that the infectious process resulting from the combined influence of neurotropic viruses may differ in important ways from infection with either agent alone, complicating both diagnosis and the interpretation of disease severity.
The literature review accompanying the case report surveys what is known about HHV-7 as a cause of meningoencephalitis. Reports of HHV-7-associated encephalitis cluster heavily among immunocompromised populations, particularly hematopoietic stem cell transplant recipients, in whom the virus has been detected in cerebrospinal fluid during episodes of neurological deterioration. In immunocompetent patients, documented cases are rare and often rest on single-center detections without definitive proof of causality. This evidentiary gap mirrors a broader problem in clinical virology: the widespread use of sensitive multiplex PCR panels on cerebrospinal fluid increasingly uncovers viral sequences whose clinical significance is uncertain. A positive PCR result for a latent herpesvirus in a patient with another clear diagnosis, such as tick-borne encephalitis, exemplifies the interpretive tightrope that clinicians must walk between over-attributing disease to an incidental finding and missing a genuine co-pathogen.
In the present case, the practical outcome was favorable. The patient received prescribed therapy, her condition improved steadily, and she was discharged on the twenty-third day of her hospital stay. The report does not claim that anti-herpesvirus treatment was decisive, nor does it attribute any specific portion of her neurological illness to HHV-7; instead, it uses the case to illustrate how diagnostic reasoning must accommodate the possibility of coexisting viral processes. For clinicians working in tick-borne encephalitis endemic zones, the case is a reminder that a confirmed flaviviral diagnosis does not automatically explain every feature of a patient’s course, and that molecular testing of cerebrospinal fluid can reveal additional agents whose contribution requires careful weighing.
Beyond its immediate clinical message, the case carries implications for surveillance and research. Tick-borne encephalitis is expanding its geographic footprint in Europe, with rising case numbers and newly affected regions reported in recent years, and Ukraine sits within the endemic belt where awareness of the disease is critical for early diagnosis and supportive care. As molecular diagnostics become more widely deployed, detecting additional viruses in the cerebrospinal fluid of TBE patients will likely become more common, and the field will need systematic studies, with quantitative viral loads, longitudinal sampling, and matched controls, to determine when such findings represent reactivation, co-infection, or noise. The Lviv team’s report, grounded in a single well-documented patient and an honest acknowledgment of interpretive complexity, contributes to exactly that foundation. It also underscores a broader truth of modern virology: the human body is a layered ecosystem of persistent viruses, and acute infections can disturb that equilibrium in ways medicine is only beginning to map.
For now, the case stands as both a clinical observation and a caution. A febrile immunocompetent woman with meningoencephalitis, a tick bite, and serology pointing squarely at tick-borne encephalitis virus turned out to carry the DNA of a second neurotropic virus in her spinal fluid. Her recovery suggests that the combined infection was survivable with appropriate care, but the virological questions her case raises, about viral interference, latency, and the true pathogenic potential of HHV-7 in the healthy brain, remain open. The authors’ literature review makes clear that answering them will require more than isolated case reports; it will require the kind of structured, comparative research that turns surprising laboratory findings into actionable clinical knowledge.
Subject of Research: Co-infection of tick-borne encephalitis virus and human herpesvirus 7 in a patient with meningoencephalitis
Article Title: Tick-borne encephalitis co-occurring with human herpesvirus 7 replication: a case report and literature review
Article References: Zubach, O., Prykuda, N., Zadorozhnyi, A., Fedorenko, S., Zbarashchuk, L., Romaniuk, U., & Zinchuk, A. (2026). Tick-borne encephalitis co-occurring with human herpesvirus 7 replication: a case report and literature review. Virology Journal. https://doi.org/10.1186/s12985-026-03313-z
Image Credits: AI Generated
DOI: 10.1186/s12985-026-03313-z
Keywords: tick-borne encephalitis, human herpesvirus 7, meningoencephalitis, viral co-infection, cerebrospinal fluid, PCR diagnostics, flavivirus, herpesvirus latency, immunocompetent patient, case report, neurotropic viruses, Ukraine
Cite Scienmag News
APA MLA Chicago
Cassandra Pierce. (September 26, 2026). When Two Viruses Invade the Brain Together: A Rare Case of Tick-Borne Encephalitis With HHV-7. Scienmag. https://scienmag.com/when-two-viruses-invade-the-brain-together-a-rare-case-of-tick-borne-encephalitis-with-hhv-7/
Cassandra Pierce. “When Two Viruses Invade the Brain Together: A Rare Case of Tick-Borne Encephalitis With HHV-7.” Scienmag, 26 September 2026, https://scienmag.com/when-two-viruses-invade-the-brain-together-a-rare-case-of-tick-borne-encephalitis-with-hhv-7/. Accessed 26 September 2026.
Cassandra Pierce. “When Two Viruses Invade the Brain Together: A Rare Case of Tick-Borne Encephalitis With HHV-7.” Scienmag. September 26, 2026. https://scienmag.com/when-two-viruses-invade-the-brain-together-a-rare-case-of-tick-borne-encephalitis-with-hhv-7/
Copy citation Download RIS
Tags: case reportcerebrospinal fluidcerebrospinal fluid analysisco-infection with HHV-7diagnostic challenges in viral CNS infectionsflavivirusherpesvirus latencyhuman herpesvirus 7immunocompetent patientlymphocytic pleocytosismeningoencephalitisneurological manifestations of viral infectionsneurotropic virusesPCR diagnosticsTick-borne encephalitistick-endemic regionsUkraineviral brain infectionsviral co-infectionviral co-infection case studyviral meningoencephalitis
